Direction Centrale du Service de Santé des Armées   Report issue

Government Phase 2 Phase 3
Founded: Paris France (1962)

Organization Overview

First Clinical Trial
2008
NCT01028339
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Direction Centrale du Service de Santé des Armées | Direction Centrale du Service de Santé des Armées (DCSSA) | Pierre-Julien CUNGI | Statistical and methodological investigator - Laboratoire TIMC UMR 5525 CNRS Equipe Themas

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Blood Coagulation Disorders (Phase 3)

Brain Injuries (Phase 3)

Brain Injuries, Traumatic (Phase 3)

Craniocerebral Trauma (Phase 2)

Hemorrhage (Phase 3)

Hemostatic Disorders (Phase 3)

Hyperhidrosis (Phase 3)

Pneumonia (Phase 3)

Shock (Phase 3)

Shock, Septic (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 9
  • # of Trial APIs: 15